http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0729370-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41686a979f961bce6a9855b4b409a5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-044
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32
filingDate 1994-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bccbb043e5786aba653de2a222167369
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_215d4400a5b2981739e6cc6bced3f1e1
publicationDate 1996-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0729370-A1
titleOfInvention Iontophoretic drug delivery system and method
abstract An iontophoretic drug delivery device (20) includes a power source (23) and an electrode assembly (24) containing at least two electrodes (32, 42) in electrical contact with a first reservoir (34) and a second reservoir (44) or at least three electrodes in a three electrode embodiment, with the third electrode (52) in electrical contact with a third reservoir (54). The present invention includes in its two electrode embodiment a switch (56) for reversing the flow of current or in its three electrode embodiment a switch (66) for switching the flow of current, so as to reduce sensation. The devices also include a timer (58) for controlling the amount of time the electrical current flows in each direction. The devices are timed to deliver an active agent to the area approximate the second reservoir (44) when the electrical current flows in the other direction.
priorityDate 1993-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5006108-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919

Total number of triples: 26.